Alliancebernstein L.P. Biotechnology

Alliancebernstein L.P.

$290 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
SVRA Savara Inc	$479M	$312,000 0.0% of portfolio	137,090	Q2 2025 Added 36.04%
ATXS Astria Therapeutics, Inc.	$186M	$310,000 0.0% of portfolio	57,970	Q2 2025 Added 7.31%
CDXC Chroma Dex Corp.	$420M	$309,000 0.0% of portfolio	50,350	Q2 2025 Added 401.0%
HUMA Humacyte, Inc.	$159M	$304,000 0.0% of portfolio	145,560	Q2 2025 Added 121.92%
CMPX Compass Therapeutics, Inc.	$372M	$303,000 0.0% of portfolio	116,670	Q2 2025 Added 444.17%
ERAS Erasca, Inc.	$282M	$296,000 0.0% of portfolio	233,430	Q2 2025 Added 51.1%
ALDX Aldeyra Therapeutics, Inc.	$295M	$289,000 0.0% of portfolio	75,550	Q2 2025 Added 28.82%
CDXS Codexis, Inc.	$142M	$288,000 0.0% of portfolio	118,130	Q2 2025 Added 0.27%
GLUE Monte Rosa Therapeutics, Inc.	$560M	$286,000 0.0% of portfolio	63,480	Q2 2025 Added 80.65%
ALT Altimmune, Inc.	$185M	$277,000 0.0% of portfolio	71,760	Q3 2024 Reduced 24.88%
KOD Kodiak Sciences Inc.	$960M	$270,000 0.0% of portfolio	72,610	Q2 2025 Added 9.01%
YMAB Y M Abs Therapeutics, Inc.	$376M	$267,000 0.0% of portfolio	59,380	Q2 2025 Added 8.4%
AURA Aura Biosciences, Inc.	$173M	$260,000 0.0% of portfolio	41,660	Q2 2025 Added 74.9%
ENTA Enanta Pharmaceuticals Inc	$224M	$255,000 0.0% of portfolio	33,740	Q2 2025 Added 12.69%
FDMT 4 D Molecular Therapeutics, Inc.	$361M	$242,000 0.0% of portfolio	65,290	Q2 2025 Added 16.86%
FATE Fate Therapeutics Inc	$115M	$210,000 0.0% of portfolio	187,700	Q2 2025 Added 28.05%
OMER Omeros Corp	$445M	$202,000 0.0% of portfolio	67,590	Q2 2025 Added 32.56%
AMLX Amylyx Pharmaceuticals, Inc.	$804M	$196,000 0.0% of portfolio	30,600	Q2 2025 New
VYGR Voyager Therapeutics, Inc.	$166M	$182,000 0.0% of portfolio	58,830	Q2 2025 Added 60.08%
LRMR Larimar Therapeutics, Inc.	$164M	$180,000 0.0% of portfolio	62,380	Q2 2025 Added 88.69%
CHRS Coherus Bio Sciences, Inc.	$120M	$155,000 0.0% of portfolio	213,590	Q2 2025 Added 13.36%
CRDF Cardiff Oncology, Inc.	$95.8M	$153,000 0.0% of portfolio	48,730	Q2 2025 Added 369.46%
TRDA Entrada Therapeutics, Inc.	$208M	$152,000 0.0% of portfolio	22,700	Q2 2025 Added 77.76%
DSGN Design Therapeutics, Inc.	$348M	$151,000 0.0% of portfolio	45,030	Q2 2025 Added 6.99%
NKTX Nkarta, Inc.	$94.4M	$149,000 0.0% of portfolio	89,870	Q2 2025 Added 11.38%
ADCT Adc Therapeutics Sa	$313M	$132,000 0.0% of portfolio	49,590	Q2 2025 Added 125.2%
ALEC Alector, Inc.	$109M	$130,000 0.0% of portfolio	92,940	Q2 2025 Added 13.2%
LIFE A Tyr Pharma Inc	$53.2M	$119,000 0.0% of portfolio	64,480	Q2 2025 Added 24.2%
FHTX Foghorn Therapeutics Inc.	$156M	$117,000 0.0% of portfolio	25,050	Q2 2025 Added 44.13%
THRD Third Harmonic Bio, Inc.	$217M	$113,000 0.0% of portfolio	20,830	Q2 2025 Added 74.6%
SLS Sellas Life Sciences Group, Inc.	$34.1M	$109,000 0.0% of portfolio	49,960	Q2 2025 New
RZLT Rezolute, Inc.	$346M	$107,000 0.0% of portfolio	24,210	Q2 2025 New
CVAC Cure Vac N.V.	$994M	$106,000 0.0% of portfolio	19,691	Q3 2023 New
ABEO Abeona Therapeutics Inc.	$27.1M	$101,000 0.0% of portfolio	17,920	Q2 2025 New
SCPH Sc Pharmaceuticals Inc.	$155M	$80,000 0.0% of portfolio	21,010	Q2 2025 Added 38.13%
CRVS Corvus Pharmaceuticals, Inc.	$356M	$68,000 0.0% of portfolio	17,120	Q2 2025 New
INMB Inmune Bio, Inc.	$31.9M	$50,000 0.0% of portfolio	21,950	Q2 2025 New
PBYI Puma Biotechnology, Inc.	$224M	$47,000 0.0% of portfolio	13,800	Q2 2025 New
GOSS Gossamer Bio, Inc.	$216M	$32,000 0.0% of portfolio	26,420	Q2 2025 New
PLX Protalix Bio Therapeutics, Inc.	$116M	$17,000 0.0% of portfolio	11,720	Q2 2025 New
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	3,825,793	Q2 2025 Reduced 2.47%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.